| Issue Date | Title | Author(s) |
| 1 | 2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
| 2 | 2015 | Effects of placental derived mesenchymal stem cells on experimental asthma | Sözmen, Çağlayan S.; Karaman, M.; Baran, Yusuf ; Micili, Cilaker S.; Kartal Yandım, Melis; Kiraz, Yağmur ; Karaman, O. |
| 3 | 2015 | Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients | Kiraz, Yağmur ; Saydam, Güray; Şahin, Fahri; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Baran, Yusuf |
| 4 | 2014 | JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patients | Kiraz, Yağmur ; Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf |
| 5 | 2014 | A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17 | Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali |
| 6 | 2015 | Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines | Kacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf |
